1. Home
  2. Category
  3. Cancer Type

Head and Neck Cancer

NCPD Article

Comprehensive Geriatric Assessment: A Case Report on Personalizing Cancer Care of an Older Adult Patient With Head and Neck Cancer

Fay J. Strohschein
Allison Loucks
Rana Jin
Brandy Vanderbyl
CJON 2020, 24(5), 514-525 DOI: 10.1188/20.CJON.514-525
Background: Understanding multidimensional screening and assessment is key to optimizing cancer care in older adults. Objectives: This article aims to present comprehensive geriatric assessment (CGA) as an approach to personalizing care for older adults with cancer. Methods: A case study of an 89-...
0
No votes yet
Read this Article
NCPD Article

Nutritional Screening: Development and Implementation of a Protocol in Patients With Head and Neck Cancer

Ashley Laursen
CJON 2020, 24(4), 415-420 DOI: 10.1188/20.CJON.415-420
Background: Half of all patients with head and neck cancer are malnourished at the time of diagnosis. Although nutritional status can be predictive of patient-related outcomes, nutritional screening protocols have not been widely accepted as standard of care. Objectives: This article aims to...
0
No votes yet
Read this Article
NCPD Article

HPV-Positive Oropharyngeal Cancer: The Nurse’s Role in Patient Management of Treatment-Related Sequelae

Jennifer Cerar
Katherine B. Bryant
Scarlett E. Shoemaker
Linda Battiato
Gloria Wood
CJON 2020, 24(2), 153-159 DOI: 10.1188/20.CJON.153-159
Background: Patients diagnosed with oropharyngeal cancer (OPC) make up about 3% of all new cancer cases in the United States, with increasing numbers of these patients being diagnosed aged younger than 45 years and with human papillomavirus (HPV)–positive disease. Treatment effects may alter...
0
No votes yet
Read this Article
NCPD Article
Open Access Article

PD-1 Inhibitors: Safety of Use and Management of Immune-Mediated Adverse Reactions in Patients With Head and Neck Cancer

Rebecca L. Lewis
Kristen L. Miller
CJON 2019, 23(6), 627-638 DOI: 10.1188/19.CJON.627-638
Background: Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) with programmed cell death protein 1 (PD-1) inhibitors has been associated with risk of developing immune-mediated adverse reactions (IMARs). Objectives: This review provides nurses...
5
Average: 5 (1 vote)
Read this Article
NCPD Article

Financial Vulnerability: A Case Study Involving a Patient With Head and Neck Cancer

Eden R. Brauer
Elizabeth G. Morasso
CJON 2019, 23(5), 31-35 DOI: 10.1188/19.CJON.S2.31-35
Background: Patients with head and neck cancer (HNC) face unique financial challenges. Even with stable income and health insurance, many patients become overwhelmed with direct and indirect treatment-associated costs. Objectives: This article discusses how prolonged financial burden in patients...
0
No votes yet
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.